Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,266 | 22,610 | 29,132 | 34,911 | 42,596 |
| Receivables | 2,144 | 2,684 | 1,945 | 2,390 | 793 |
| TOTAL | $83,410 | $25,294 | $31,077 | $37,301 | $43,389 |
| Non-Current Assets | |||||
| PPE Net | 14,537 | 12,112 | 10,458 | 8,383 | 6,841 |
| Other Non-Current Assets | 724 | 714 | 650 | 554 | 581 |
| TOTAL | $15,261 | $12,826 | $11,108 | $8,937 | $7,422 |
| Total Assets | $98,671 | $38,120 | $42,185 | $46,238 | $50,811 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,967 | 6,900 | 6,214 | 5,693 | 5,527 |
| TOTAL | $21,530 | $6,900 | $6,214 | $5,693 | $5,527 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,563 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,209 | 1,143 | 1,056 | 917 | 937 |
| TOTAL | $61,258 | $1,143 | $1,056 | $917 | $937 |
| Total Liabilities | $82,788 | $8,043 | $7,270 | $6,610 | $6,464 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,075 | 7,727 | 7,651 | 7,602 | 7,594 |
| Common Shares | 81 | N/A | 76 | 76 | 76 |
| Retained earnings | -106,450 | N/A | -85,620 | -80,193 | -75,010 |
| Other shareholders' equity | 0 | 30,077 | 0 | 0 | 0 |
| TOTAL | $15,883 | $30,077 | $34,915 | $39,628 | $44,347 |
| Total Liabilities And Equity | $98,671 | $38,120 | $42,185 | $46,238 | $50,811 |